Introducing Slate 2.0: Make Discovery More Inevitable and Less Accidental. See What’s New

Beyond Antibiotics: Mapping the Technology Gaps in Preventing BV Recurrence

Antibiotics can successfully treat bacterial vaginosis (BV), but preventing it from returning remains a major challenge. In a 12-month follow-up study of women treated with oral metronidazole, 58% experienced BV recurrence within a year. While antibiotics reduce BV-associated bacteria, they do not necessarily restore the protective vaginal microbiome needed for long-term recovery. This is creating […]

4 R&D Challenges Shaping the Future of Sustainable Surfactants 

Investment in biosurfactants is growing, but patent activity tells a different story. AmphiStar secured €12.5 million to advance biosurfactant production, while Dispersa raised CAD 5.8 million to scale surfactants made from waste materials. Yet, our analysis found no new patent publications in the specific microbial fermentation and waste-based production clusters examined over the past 24 […]

Microencapsulation vs. Nanoparticles for Yogurt Probiotics: What Industry Patents Reveal

On paper, protecting probiotics in yogurt looks like a solved problem. Academic labs have spent years developing microencapsulation coatings, nanoemulsions, and protein-based carriers to shield sensitive bioactives through processing, storage, and digestion. The patents are not there. When Slate analyzed the patent and research landscape, the bioactive-protection cluster held just one published patent. Traditional probiotic […]

5 Underexplored White Spaces in Probiotic Delivery for High-Protein Yogurt

Probiotic innovation in high-protein yogurt is growing quickly, but most of that activity is focused on the strains themselves rather than how those strains survive processing. Between 2024 and 2026, the probiotic fermentation cluster grew 2.1×, with 582 innovations filed. In comparison, bioactive additive integration recorded just one patent. This 582:1 gap points to an […]

The Future of Bromine: Regulation, Supply Risks, and the Limits of Chemical Substitution

Bromine still performs in many industrial applications. The bigger question is which applications still justify the supply, qualification, customer, and regulatory risks that come with it. A brominated material can meet every engineering specification and still become the wrong business choice. Sometimes, the trigger isn’t a new regulation. It’s a customer requirement. Lenovo’s environmental targets […]

The Hidden R&D Gaps Between Maternal Nutrition Diagnostics and Formulations

What if some of the most important research shaping personalized maternal nutrition is happening outside the R&D labs of companies like Nestlé and Bayer? An analysis generated using Slate reveals an interesting pattern. Ahmadu Bello University in Nigeria appears across five nutritional diagnostic research clusters, while Nestlé, despite contributing 44 innovations in reproductive health formulations, […]

Why a Specialized AI R&D Tool Could Be Your Next Fit

An oil and gas company thought its patent monitoring was working fine. Then the CEO came back from a trip and asked the team to check again. A competitor had been filing steadily in an area the team thought was quiet. They were almost a year behind. The team wasn’t careless. Their tool showed them […]

Microbiome Scalp Care vs Synthetic Surfactants Which Technology Will Shape Scalp Care by 2028?

Scalp care is attracting innovation from three very different directions. Beauty companies are developing microbiome-focused ingredients and peptides. Traditional hair care companies continue to improve surfactants and conditioning systems. Electronics companies are building devices that could change how scalp treatments are applied. So which technology is actually gaining ground? We asked Slate to investigate the […]